Skip to main content
Erschienen in: AIDS and Behavior 7/2016

29.03.2016 | Original Paper

Awareness of Pre-exposure Prophylaxis for HIV, Willingness to Use It and Potential Barriers or Facilitators to Uptake Among Men Who Have Sex with Men in Spain

verfasst von: L. Ferrer, C. Folch, P. Fernandez-Davila, A. Garcia, A. Morales, J. Belda, A. R. Susperregui, J. Casabona, Ad hoc study group for PrEP acceptability

Erschienen in: AIDS and Behavior | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

There is a lack of data on pre-exposure prophylaxis (PrEP) effectiveness in Spain. We described the awareness of and willingness to use PrEP and examined potential barriers and facilitators to their use among men who have sex with men recruited either online or in voluntary HIV testing centers in Spain. Nearly a third of men (28.7 %) were aware of PrEP and 57.6 % said they would be willing to use it if available, 16.6 % saying they would be unwilling to use PrEP and 25.8 % not being sure. Men who had heard of PrEP were more forceful in their opinions on willingness to use PrEP (willing/not willing: 29.8 %/32.6 % vs. don’t know: 21.8 %). The greatest consensus regarding more acceptable PrEP attributes was in the mode of delivery and its cost. Doctors (91 %) or pharmacists (85.3 %) were the preferred providers. The results confirm the need to inform and educate on PrEP and define implementation strategies.
Literatur
3.
Zurück zum Zitat Grant RM, Lama JR, Anderson PL, et al. Pre-exposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.CrossRefPubMedPubMedCentral Grant RM, Lama JR, Anderson PL, et al. Pre-exposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat McCormack S, Dunn DT, Desai M, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2015. doi:10.1016/S0140-6736(15)00056-2. McCormack S, Dunn DT, Desai M, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2015. doi:10.​1016/​S0140-6736(15)00056-2.
9.
Zurück zum Zitat Young I, McDaid L. How acceptable are antiretrovirals for the prevention of sexually transmitted HIV? A review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behav. 2014;18:195–216. doi:10.1007/s10461-013-0560-7.CrossRefPubMed Young I, McDaid L. How acceptable are antiretrovirals for the prevention of sexually transmitted HIV? A review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behav. 2014;18:195–216. doi:10.​1007/​s10461-013-0560-7.CrossRefPubMed
10.
Zurück zum Zitat Eisenrgerich AB, Wheelock A, Gomez GB, Garnett GP, Dybul MR, Piot PK. Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study. PLoS One. 2012;7(2):e28238. doi:10.1371/journal.pone.0028238.CrossRef Eisenrgerich AB, Wheelock A, Gomez GB, Garnett GP, Dybul MR, Piot PK. Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study. PLoS One. 2012;7(2):e28238. doi:10.​1371/​journal.​pone.​0028238.CrossRef
11.
Zurück zum Zitat Mimiaga MJ, Case P, Johnson CV, Safren SA, Mayer KH. Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education. J Acquir Immune Defic Syndr. 2009;50(1):77–83. doi:10.1097/QAI.0b013e31818d5a27.CrossRefPubMedPubMedCentral Mimiaga MJ, Case P, Johnson CV, Safren SA, Mayer KH. Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education. J Acquir Immune Defic Syndr. 2009;50(1):77–83. doi:10.​1097/​QAI.​0b013e31818d5a27​.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Golub SA, Gamarel KE, Rendina HJ, Surace A, Lelutiu-Weinberger CL. From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care STDS. 2013;27(4):248–54. doi:10.1089/apc.2012.0419.CrossRefPubMedPubMedCentral Golub SA, Gamarel KE, Rendina HJ, Surace A, Lelutiu-Weinberger CL. From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care STDS. 2013;27(4):248–54. doi:10.​1089/​apc.​2012.​0419.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Gersh JK, Fiorillo SP, Burghardt L, et al. Attitudes and barriers towards pre-exposure prophylaxis (Prep) among high-risk HIV-seronegative men who have sex with men. J AIDS Clin Res. 2014;5:335. doi:10.4172/2155-6113.1000335. Gersh JK, Fiorillo SP, Burghardt L, et al. Attitudes and barriers towards pre-exposure prophylaxis (Prep) among high-risk HIV-seronegative men who have sex with men. J AIDS Clin Res. 2014;5:335. doi:10.​4172/​2155-6113.​1000335.
16.
Zurück zum Zitat Holt M, Murphy DA, Callander D, et al. Willingness to use HIV pre-exposure prophylaxis and the likelihood of decreased condom use are both associated with unprotected anal intercourse and the perceived likelihood of becoming HIV positive among Australian gay and bisexual men. Sex Transm Infect. 2012;88(4):258–63.CrossRefPubMed Holt M, Murphy DA, Callander D, et al. Willingness to use HIV pre-exposure prophylaxis and the likelihood of decreased condom use are both associated with unprotected anal intercourse and the perceived likelihood of becoming HIV positive among Australian gay and bisexual men. Sex Transm Infect. 2012;88(4):258–63.CrossRefPubMed
19.
21.
Zurück zum Zitat Lorente N, Fugon L, Carrieri MP, et al. Acceptability of an “on demand” pre-exposure HIV prophylaxis trial among men who have sex with men living in France. AIDS Care. 2012;24(4):468–77. doi:10.1080/09540121.2011.626394.PubMed Lorente N, Fugon L, Carrieri MP, et al. Acceptability of an “on demand” pre-exposure HIV prophylaxis trial among men who have sex with men living in France. AIDS Care. 2012;24(4):468–77. doi:10.​1080/​09540121.​2011.​626394.PubMed
22.
Zurück zum Zitat Rocha LM, Campos MJ, Brito J, et al. Acceptability of PrEP among HIV negative Portuguese men who have sex with men that attended 2014 Lisbon pride fair. J Int AIDS Soc. 2014;17(4 Suppl. 3):19734. doi:10.7448/IAS.17.4.19734.PubMed Rocha LM, Campos MJ, Brito J, et al. Acceptability of PrEP among HIV negative Portuguese men who have sex with men that attended 2014 Lisbon pride fair. J Int AIDS Soc. 2014;17(4 Suppl. 3):19734. doi:10.​7448/​IAS.​17.​4.​19734.PubMed
24.
Zurück zum Zitat Diez M, Bleda MJ, Varela JR, et al. Trends in HIV testing, prevalence among first-time testers, and incidence in most-at-risk populations in Spain: the EPI-VIH Study, 2000 to 2009. Euro Surveill. 2014;19(47):20971.CrossRefPubMed Diez M, Bleda MJ, Varela JR, et al. Trends in HIV testing, prevalence among first-time testers, and incidence in most-at-risk populations in Spain: the EPI-VIH Study, 2000 to 2009. Euro Surveill. 2014;19(47):20971.CrossRefPubMed
25.
Zurück zum Zitat Centre d’Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT). SIVES 2012: Sistema integrat de vigilància epidemiològica del SIDA/VIH/ITS a Catalunya (SIVES): Informe biennal. Barcelona: Generalitat de Catalunya, Departament de Salut 2012. Technical Document CEEISCAT, 21. Centre d’Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT). SIVES 2012: Sistema integrat de vigilància epidemiològica del SIDA/VIH/ITS a Catalunya (SIVES): Informe biennal. Barcelona: Generalitat de Catalunya, Departament de Salut 2012. Technical Document CEEISCAT, 21.
28.
Zurück zum Zitat Jain S, Krakower DS, Mayer KH. The transition from postexposure prophylaxis to preexposure prophylaxis: an emerging opportunity for biobehavioural HIV prevention. Clin Infect Dis. 2015;1(60 Suppl 3):S200–4. doi:10.1093/cid/civ094.CrossRef Jain S, Krakower DS, Mayer KH. The transition from postexposure prophylaxis to preexposure prophylaxis: an emerging opportunity for biobehavioural HIV prevention. Clin Infect Dis. 2015;1(60 Suppl 3):S200–4. doi:10.​1093/​cid/​civ094.CrossRef
30.
Zurück zum Zitat Research Sigma. The Sigma Panel insight Blast 6: prospective attitudes to hiv pre-exposure prophylaxis (PrEP). London: Sigma Research; 2011. Research Sigma. The Sigma Panel insight Blast 6: prospective attitudes to hiv pre-exposure prophylaxis (PrEP). London: Sigma Research; 2011.
31.
Zurück zum Zitat Barash EA, Golden M. Awareness and use of HIV pre-exposure prophylaxis among attendees of a Seattle gay pride event and sexually transmitted disease clinic. AIDS Patient Care STDS. 2010;24(11):689–91. doi:10.1089/apc.2010.0173.CrossRefPubMed Barash EA, Golden M. Awareness and use of HIV pre-exposure prophylaxis among attendees of a Seattle gay pride event and sexually transmitted disease clinic. AIDS Patient Care STDS. 2010;24(11):689–91. doi:10.​1089/​apc.​2010.​0173.CrossRefPubMed
32.
Zurück zum Zitat Haire B. Preexposure prophylaxis-related stigma: strategies to improve uptake and adherence—a narrative review. HIV AIDS (Auckl). 2015;7:241–9. doi:10.2147/HIV.S72419. Haire B. Preexposure prophylaxis-related stigma: strategies to improve uptake and adherence—a narrative review. HIV AIDS (Auckl). 2015;7:241–9. doi:10.​2147/​HIV.​S72419.
Metadaten
Titel
Awareness of Pre-exposure Prophylaxis for HIV, Willingness to Use It and Potential Barriers or Facilitators to Uptake Among Men Who Have Sex with Men in Spain
verfasst von
L. Ferrer
C. Folch
P. Fernandez-Davila
A. Garcia
A. Morales
J. Belda
A. R. Susperregui
J. Casabona
Ad hoc study group for PrEP acceptability
Publikationsdatum
29.03.2016
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 7/2016
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-016-1379-9

Weitere Artikel der Ausgabe 7/2016

AIDS and Behavior 7/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.